ArticleFrontiers in oncology2025
Upright radiotherapy for breast cancer: a pre-clinical study considering photon and proton beam access, plus arm positioning.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Upright positioning in pediatric radiotherapy: rationale, safety considerations and a research roadmap.Technical innovations & patient support in radiation oncology · 2026Article
- Upright versus supine positioning for breast and lung radiotherapy: a pilot study on patient comfort, experience and lung function.Technical innovations & patient support in radiation oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Upright radiotherapy has gained increasing attention in recent years due to its potential advantages, including lower room costs, improved patient comfort, and possible anatomical/physiological benefits. In this pre-clinical study, we assess the feasibility of implementing upright radiotherapy for breast cancer by evaluating beam access, inframammary skin fold size, field length, and set-up comfort across a range of upright positions. Materials and methods: Twenty-one healthy participants were enrolled in the study. Each participant was set-up on an upright patient positioning system (Eve from Leo Cancer Care Ltd) with three different arm positions (arms up, arms down, and arms behind). Setups were conducted both without a bra (topless) and with the Chabner XRT Bra for Radiotherapy, an indexable bra designed for immobilisation during treatment. Optical surface scans were acquired, and the external contour of the breast was used to approximate a clinical target volume. Beam access was evaluated in multiple regions of the breast while field size and the ISF were measured for the different positions. Participants rated their comfort using a survey. ArUco markers were employed to evaluate ease of setup by measuring the unaided reproducibility of each upright position. Results: The ISF was smallest in the arms-up position when participants wore the Chabner XRT Bra. Beam access for photon treatment planning was assessed for 15 participants. Arm position significantly affected photon beam angle flexibility; with arms down, participants had fewer available angles for beam angle entry. The Chabner XRT Bra consistently reduced the required field length across all positions. Participants could typically reposition themselves with sub-centimetre accuracy, without any assistance from the study team. Conclusion: Overall, this study demonstrates the feasibility of delivering breast radiotherapy in the upright position for both photon and proton treatments. The arms-up position was preferable in terms of photon beam access. While photon beam access was limited for the arms down position, it remained achievable in the majority of cases. The use of the Chabner XRT Bra significantly reduced the size of the ISF, which may help lower skin toxicity, as well as the field length required for treatment, potentially decreasing unwanted lung dose.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.